Affordable and accessible medicines for the entire world

Trek Therapeutics is a for-profit company, organized as a public benefit corporation.  Its mission is to develop medicines to treat infectious diseases and commercialize them for global populations. The company’s founders have collectively participated in developing seven approved antiviral drugs. Our objective is to profitably develop safe, novel medicines for infectious diseases at affordable and accessible prices.

Featured News: In Vivo Article
–  HCV Patient Access: Trek Therapeutics Takes the Road Less Traveled (July 2017)